We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+4.25%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$3.31B
AUM Growth
+$234M
Cap. Flow
+$153M
Cap. Flow %
4.61%
Top 10 Hldgs %
29.6%
Holding
2,810
New
136
Increased
1,119
Reduced
861
Closed
104

Top Sells

Rank Stock Value
1
RDY icon
Dr. Reddy's Laboratories
RDY
+$3.19M
2
HD icon
Home Depot
HD
+$2.88M
3
COOP
Mr. Cooper
COOP
+$2.26M
4
PG icon
Procter & Gamble
PG
+$2.02M
5
CRM icon
Salesforce
CRM
+$1.9M

Sector Composition

Rank Sector Weight
1 Technology 22.8%
2 Financials 12.6%
3 Consumer Discretionary 7.91%
4 Healthcare 7.45%
5 Industrials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HST icon
726
Host Hotels & Resorts
HST
$16.8B
$724K 0.02%
40,819
-75
-0.2% -$1.29K
ULTA icon
727
Ulta Beauty
ULTA
$20.4B
$723K 0.02%
1,195
-6
-0.5% -$3.3K
KD icon
728
Kyndryl
KD
$2.66B
$722K 0.02%
27,187
+6,980
+35% +$189K
ACGL icon
729
Arch Capital
ACGL
$36.1B
$721K 0.02%
7,514
-462
-6% -$42.3K
SIG icon
730
Signet Jewelers
SIG
$3.55B
$721K 0.02%
8,696
AROC icon
731
Archrock
AROC
$6.33B
$719K 0.02%
27,621
+3,291
+14% +$81.8K
TPR icon
732
Tapestry
TPR
$28.8B
$717K 0.02%
5,615
-40
-0.7% -$4.57K
AEE icon
733
Ameren
AEE
$31.5B
$714K 0.02%
7,147
-189
-3% -$19.4K
PRI icon
734
Primerica
PRI
$9.81B
$713K 0.02%
2,761
-68
-2% -$17.7K
TEVA icon
735
Teva Pharmaceuticals
TEVA
$35.9B
$709K 0.02%
22,726
+836
+4% +$20.6K
VEU icon
736
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$709K 0.02%
9,636
+8,385
+670% +$610K
CAE icon
737
CAE Inc. Common Shares
CAE
$8.1B
$709K 0.02%
23,299
BP icon
738
BP
BP
$113B
$708K 0.02%
20,400
+3,847
+23% +$135K
EWBC icon
739
East-West Bancorp
EWBC
$17.9B
$707K 0.02%
6,295
+621
+11% +$65.9K
PRU icon
740
Prudential Financial
PRU
$41.7B
$706K 0.02%
6,254
+64
+1% +$6.86K
JHX icon
741
James Hardie Industries
JHX
$15.4B
$706K 0.02%
34,012
-18,467
-35% -$370K
PHG icon
742
Philips
PHG
$25.4B
$704K 0.02%
26,953
+212
+0.8% +$5.66K
ELAN icon
743
Elanco Animal Health
ELAN
$12.4B
$703K 0.02%
31,082
+23,878
+331% +$520K
RJF icon
744
Raymond James Financial
RJF
$32.5B
$703K 0.02%
4,380
-81
-2% -$13.1K
DOCS icon
745
Doximity
DOCS
$3.67B
$700K 0.02%
15,807
+8,059
+104% +$452K
AR icon
746
Antero Resources
AR
$10.9B
$700K 0.02%
20,306
+17
+0.1% +$576
ERIC icon
747
Ericsson
ERIC
$30.7B
$699K 0.02%
72,481
+164
+0.2% +$1.55K
BIO icon
748
Bio-Rad Laboratories Class A
BIO
$8.42B
$699K 0.02%
2,308
CNOB icon
749
Center Bancorp
CNOB
$1.63B
$699K 0.02%
26,651
-136
-0.5% -$3.44K
RYAN icon
750
Ryan Specialty Holdings
RYAN
$5.41B
$697K 0.02%
13,493
+11,950
+774% +$655K

Similar funds

Quadrant Capital Group's Q4 2025 Portfolio in Review

As of Q4 2025, Quadrant Capital Group held 2,810 positions worth $3.31B, up 7.6% from $3.08B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Quadrant Capital Group deployed $153M of net new capital in Q4 2025, opening 136 new positions and adding to 1,119 existing holdings. Its largest new stake was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dr. Reddy's Laboratories, an estimated $3.19M trimmed.

  • Quadrant Capital Group's largest Q4 2025 buy was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.
  • Quadrant Capital Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $16.7M increase.
  • Quadrant Capital Group's biggest Q4 2025 reduction was Dr. Reddy's Laboratories, cutting an estimated $3.19M.
  • Quadrant Capital Group fully exited Mr. Cooper in Q4 2025, selling an estimated $2.26M.
  • Quadrant Capital Group's ten largest holdings make up 30% of its $3.31B portfolio in Q4 2025.
  • Quadrant Capital Group opened 136 new positions and closed 104 in Q4 2025.
  • Quadrant Capital Group's portfolio value rose 7.6% quarter-over-quarter to $3.31B.

Based on Quadrant Capital Group's 13F filing for Q4 2025, filed 13 Feb 2026.